These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2902671)

  • 61. [The influence of serum theophylline concentration on the bronchodilating effect of salbutamol inhalation for bronchial asthma].
    Tsukioka K; Nakamata M; Kondo A; Hashimoto T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Jul; 28(7):950-5. PubMed ID: 1977948
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Oral beta 2-selective adrenergic bronchodilators.
    Grassi V; Daniotti S; Schiassi M; Dottorini M; Tantucci C
    Int J Clin Pharmacol Res; 1986; 6(2):93-103. PubMed ID: 2873108
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
    D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
    JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Long-term effects of a long-acting beta 2-adrenoceptor agonist, salmeterol, on airway hyperresponsiveness in patients with mild asthma.
    Cheung D; Timmers MC; Zwinderman AH; Bel EH; Dijkman JH; Sterk PJ
    N Engl J Med; 1992 Oct; 327(17):1198-203. PubMed ID: 1357550
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Salmeterol xinafoate in asthmatic patients under consideration for maintenance oral corticosteroid therapy. UK Study Group.
    Boyd G
    Eur Respir J; 1995 Sep; 8(9):1494-8. PubMed ID: 8575574
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Inhaled steroid/long-acting beta 2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients.
    Lötvall J; Langley S; Woodcock A
    Respir Res; 2006 Aug; 7(1):110. PubMed ID: 16919161
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma.
    Pearlman DS; Chervinsky P; LaForce C; Seltzer JM; Southern DL; Kemp JP; Dockhorn RJ; Grossman J; Liddle RF; Yancey SW
    N Engl J Med; 1992 Nov; 327(20):1420-5. PubMed ID: 1357554
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma.
    Rabe KF; Jörres R; Nowak D; Behr N; Magnussen H
    Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1436-41. PubMed ID: 8503554
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A randomized, double-blind trial of the effect of treatment with formoterol on clinical and inflammatory parameters of asthma in children.
    Stelmach I; Gorski P; Jerzynska J; Stelmach W; Majak P; Kuna P
    Ann Allergy Asthma Immunol; 2002 Jul; 89(1):67-73. PubMed ID: 12141723
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Randomised, double-blind, placebo-controlled, cross-over single dose study of the bronchodilator duration of action of combination fluticasone furoate/vilanterol inhaler in adult asthma.
    Braithwaite I; Williams M; Power S; Pilcher J; Weatherall M; Baines A; Moynihan J; Kempsford R; Beasley R;
    Respir Med; 2016 Oct; 119():115-121. PubMed ID: 27692131
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of beta 2-agonists during cardiopulmonary exercise test in COPD patients.
    Malerba M; Boni E; Romagnoni G; Filippi B; Politi A; Giustina A; Tantucci C; Grassi V
    Monaldi Arch Chest Dis; 1994 Dec; 49(5):389-93. PubMed ID: 7841973
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The utility of a long-acting sympathomimetic agent, procaterol, for nocturnal asthma.
    Baughman RP; Loudon RG
    Chest; 1988 Feb; 93(2):285-8. PubMed ID: 2962837
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Histamine-induced bronchospasm. Its reproducibility and usage in clinical evaluation of the sub-threshold bronchodilating dose of a new beta-agonist, KWD 2131.
    Hegardt B; Löwhagen O; Svedmyr N
    Allergy; 1980 Mar; 35(2):113-21. PubMed ID: 6104452
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Risk/benefit ratio of long-term treatment with beta 2-adrenoceptor agonists.
    Ziment I
    Lung; 1990; 168 Suppl():168-76. PubMed ID: 1974672
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of outpatient treatment of asthma with beta agonists on the response to sympathomimetics in an emergency room.
    Rossing TH; Fanta CH; McFadden ER
    Am J Med; 1983 Nov; 75(5):781-4. PubMed ID: 6139021
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Atrial natriuretic factor (ANF) is a potent bronchodilator in asthma.
    Chanez P; Mann C; Bousquet J; Chabrier PE; Godard P; Braquet P; Michel FB
    J Allergy Clin Immunol; 1990 Sep; 86(3 Pt 1):321-4. PubMed ID: 2145347
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Randomized, Multicenter Clinical Study of Tratinterol Hydrochloride Tablets for the Treatment of Bronchial Asthma.
    Kong L; Liu J; Gu G; Huo J; Ma Z; Shao Y; Sun S; Yuan Y; Zhu S; Yao C; Du G; Cheng M; Kang J
    Clin Ther; 2015 Jun; 37(6):1248-58. PubMed ID: 25857594
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The inhibitory effect of a selective alpha 2-adrenergic receptor antagonist on moderate- to severe-type asthma.
    Yoshie Y; Iizuka K; Nakazawa T
    J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):747-52. PubMed ID: 2572618
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of THIP on chronic anxiety.
    Hoehn-Saric R
    Psychopharmacology (Berl); 1983; 80(4):338-41. PubMed ID: 6414002
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.
    Baker JG; Shaw DE
    Handb Exp Pharmacol; 2024; 285():369-451. PubMed ID: 37709918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.